Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
FDA Clearance
BioMérieux gets FDA 510(k) clearance, CLIA waiver approval for panel
BioMérieux's Biofire Spotfire Respiratory/Sore Throat Panel has received dual FDA 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval.
Featured
Mergers & Acquisitions
Labcorp acquires BioReference Health assets
Skin Cancer
Castle Biosciences shares melanoma test study data at SSO 2024
Latest News
Ibex presents new study data for AI-powered cancer diagnostics platform
March 26, 2024
Eventually, an oral cancer diagnosis may be a lick away
March 28, 2024
AbbVie to buy Landos Biopharma for up to $212M
March 25, 2024
Study sheds light on the organization of immune cells in tumors
March 27, 2024
Business Insights
FDA Clearance
BioMérieux gets FDA 510(k) clearance, CLIA waiver approval for panel
Mergers & Acquisitions
Labcorp acquires BioReference Health assets
Mergers & Acquisitions
AbbVie to buy Landos Biopharma for up to $212M
Regulatory Approval
Bio-Techne receives IVDR certification for chronic myeloid leukemia monitoring test
Diagnostic Technologies
Artificial Intelligence
Ibex presents new study data for AI-powered cancer diagnostics platform
Emerging Technology
Eventually, an oral cancer diagnosis may be a lick away
Financing
Protein design firm Profluent raises $35M in funding
Gene expression
MIT team develops genome-editing approach for cancer mutation screening
Diseases
Skin Cancer
Castle Biosciences shares melanoma test study data at SSO 2024
Artificial Intelligence
Ibex presents new study data for AI-powered cancer diagnostics platform
Mergers & Acquisitions
AbbVie to buy Landos Biopharma for up to $212M
Cancer
Study sheds light on the organization of immune cells in tumors
More from LabPulse.com
Bio-Techne receives IVDR certification for chronic myeloid leukemia monitoring test
By
LabPulse.com staff writers
Bio-Techne has announced that Asuragen, part of its molecular diagnostics division, has completed class C certification under the new European Union IVDR for its QuantideX qPCR BCR-ABL IS kit for monitoring chronic myeloid leukemia.
March 22, 2024
Protein design firm Profluent raises $35M in funding
By
LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
MIT team develops genome-editing approach for cancer mutation screening
By
Matt Limb
Scientists say they have developed a method to screen cancer-associated genetic mutations more easily and quickly than any existing approach.
March 22, 2024
Highlights of March 2024 LDT hearing with lawmakers
By
Liz Carey
The VALID Act appeared to win hearts over the hammer of a forthcoming FDA final rule expected to drop heavy regulations on clinical laboratory developed tests (LDTs), a hearing of the House Subcommittee on Health revealed Thursday.
March 22, 2024
ChromaCode partners with the Medical College of Georgia on NSCLC assay validation
By
LabPulse.com staff writers
ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
March 21, 2024
WHO launches new guidance on TB diagnostics
By
LabPulse.com staff writers
The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.
March 21, 2024
QDx Pathology Services to adopt Proscia's digital pathology software
By
LabPulse.com staff writers
QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory, is working with digital pathology software firm Proscia to deploy Proscia's software in its Edison, NJ, laboratory.
March 20, 2024
Bluebird Bio secures up to $175M in debt financing
By
LabPulse.com staff writers
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital, having entered into a five-year term loan facility that provides funds in separate tranches.
March 18, 2024
AI foundation models set new benchmarks in computational pathology
By
Nick Paul Taylor
Mass General Brigham researchers have published a pair of papers on artificial intelligence (AI) systems that could improve tasks that include the analysis of pathology images and identification of rare diseases.
March 20, 2024
Siemens Healthineers to close Fast Track Diagnostics unit
By
LabPulse.com staff writers
Siemens Healthineers intends to close its Fast Track Diagnostics unit by September 2024.
March 19, 2024
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By
LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
Curio Bioscience to offer single-cell spatial mapping kit
By
Matt Limb
Curio Bioscience is offering researchers early access to a product which it claims is the first in the world to transform single-cell genomics data into spatial context.
March 19, 2024